The immature platelet fraction, a predictive tool for early recovery from dengue-related thrombocytopenia: a

Visula Abeysuriya1, Suranjith L Seneviratne1,2, Primesh de Mel1

  • 1Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo 00200, Sri Lanka.

Abstract

Insights

Immature platelet fraction (IPF%) can predict early recovery from dengue-related thrombocytopenia. Higher IPF% on days 2 and 3 of illness indicates faster platelet count normalization, aiding clinical management.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Dengue virus infection frequently causes thrombocytopenia, complicating patient management.
  • Predictive markers for timely recovery from dengue-associated low platelet counts are limited.
  • Immature platelet fraction (IPF%) reflects bone marrow megakaryopoiesis and may indicate recovery potential.

Purpose of the Study:

  • To evaluate the predictive capability of IPF% on days 2 and 3 of illness for recovery from thrombocytopenia in dengue patients.
  • To determine the diagnostic accuracy of IPF% in forecasting platelet count normalization.

Main Methods:

  • Prospective study of 240 dengue patients diagnosed via NS1 antigen or IgM.
  • IPF% measured using Sysmex-XN-1000 automated hematology analyzer.
  • Clinical data collected from electronic medical records; statistical analysis performed using SPSS v20.

Main Results:

  • An IPF% >7.15% on day 2 predicted platelet recovery (≥60×10^9/L) by day 7 with 80% sensitivity and 70.4% specificity.
  • An IPF% >7.25% on day 3 predicted recovery by day 8 with 88.9% sensitivity and 47.1% specificity.
  • Lower IPF% observed in severe dengue cases; platelet recovery occurred within 48 hours of peak IPF%.

Conclusions:

  • IPF% on days 2 and 3 of dengue illness shows promise as a predictive tool for early platelet count recovery.
  • IPF% can aid clinicians in anticipating recovery timelines and managing dengue-related thrombocytopenia.
  • This biomarker may help differentiate recovery trajectories in dengue patients.